LabCentral "Golden Ticket" Submission


ristol-Myers Squibb is excited to be a platinum sponsor of LabCentral, an innovative, shared laboratory space in Cambridge, MA designed as a launch pad for life-science and biotech start-ups.   As a platinum sponsor, Bristol-Myers Squibb is sponsoring a contest to award two “Golden Tickets” through its 2018 Golden Ticket Program, each representing one year of underwritten individual laboratory bench space at LabCentral.  

Bristol-Myers Squibb is now accepting applications for its 2018 Golden Ticket Program and will accept applications until July 6, 2018.  Companies engaged in therapeutic research in the fields of Oncology, Immunology, Cardiovascular Disease, or Fibrotic Diseases are encouraged to apply.  Companies pursuing research in novel target identification, drug delivery, discovery technology platforms, and translational R&D are also encouraged to apply.   

A Golden Ticket is good for one individual bench in LabCentral’s shared facility, including all resident benefits, subject to LabCentral’s policies and the Program Rules. LabCentral provides fully equipped, permitted, and supported lab space for biomedical research, plus programming and unmatched networking opportunities to help start-ups advance their science and build their companies. Visit: to learn more.

To apply, please download and complete the Application, and submit to by 11:59 PM on July 6, 2018.  

A sub-set of applicants will be identified as finalists.  Finalists will present their concept to the Cambridge life science community as part of an innovation showcase during Bristol-Myers Squibb’s Pharma Day with MassBio, to be held on or around September 13.  All innovation showcase presentations will be non-confidential, last no more than 10 minutes, and be held in the offices of MassBio, in Cambridge, MA.

Awardees will be announced following the innovation showcase.

Bristol-Myers Squibb 2018 Golden Ticket Program Official Rules identify the process for selecting the winners of the contest, the judging criteria and other terms and conditions of the Program.  By submitting an Application, Applicants represent and warrant that they have read and agree to the Rules.

Hear from the winners of Bristol-Myers Squibb’s Golden Tickets for LabCentral on what their Golden Ticket win has meant for them.  


Laura Indolfi, CEO of PanTher Therapeutics

Carl Schoellhammer, CEO of Suono Bio

Abdul Hakkim and Tobias Fuchs